Parkman Healthcare Partners LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1777015
STAMFORD, CT
Position in KNSA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,479,709
-$14,960,121 QoQ
Shares Held
259,184
-61.0% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Parkman Healthcare Partners LLC holds $82,007,868 across 7 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
202,907 | $16,796,641 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,624,279 | $16,242,790 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
364,269 | $14,945,957 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,807,621 | $14,316,358 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
541,190 | $9,367,998 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
398,782 | $7,162,124 | |
| 7 | VTRS |
Viatris Inc
|
200,000 | $3,176,000 |
All Filings in KNSA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,479,709 | 259,184 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,439,830 | 665,208 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $26,077,917 | 671,592 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,524,985 | 488,796 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,937,812 | 762,621 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,140,660 | 765,453 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,873,547 | 755,244 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,082,141 | 647,142 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||